Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07433660 · ClinicalTrials.gov registry record
WellSpan-THRIVE Cancer QOL Study
A clinical trial of Cancer - Ovarian and Cancer (With or Without Metastasis), sponsored by WellSpan Health.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 5
- Study locations
NCT07433660: Recruiting study of Cancer - Ovarian and Cancer (With or Without Metastasis), sponsored by WellSpan Health.
NCT07433660 is a study of Cancer - Ovarian and Cancer (With or Without Metastasis) that is actively recruiting participants, run by WellSpan Health. The registered enrollment target is 1,000 participants, above the 113-participant average among 4 other Cancer - Ovarian trials with a reported enrollment target (785% higher). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07433660, a study of Cancer - Ovarian and Cancer (With or Without Metastasis), is actively recruiting participants, sponsored by WellSpan Health.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.
Primary Outcome
Quality of Life Differences based on Race or Ethnicity or Gender based on Quality-of-life questionnaire. We will look for changes in each question on Quality-of-life from baseline to 6-12-18-24 months.
Conditions Studied
Study Locations (5)
Pennsylvania
- WellSpan Medical Oncology & Hematology - Chambersburg
- WellSpan Ephrata Cancer Center - Ephrata
- WellSpan Adams Cancer Center - Gettysburg
- WellSpan Sechler Family Cancer Center - Lebanon
- WellSpan York Cancer Center - York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-02 |
| Est. Completion | 2031-12 |
What NCT07433660 shows while recruiting
NCT07433660 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 113-participant average among 4 other Cancer - Ovarian trials with a reported enrollment target (785% higher).
The record links to 6 conditions, with Cancer - Ovarian appearing as the primary indexed condition, and to 0 interventions.
NCT07433660 lists 5 locations in 1 state (Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT07433660 about?
NCT07433660 is a clinical study titled "WellSpan-THRIVE Cancer QOL Study". Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being...
What is the current status of trial NCT07433660?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-02. Estimated completion is 2031-12.
What conditions does trial NCT07433660 study?
This clinical trial studies the following conditions: Cancer - Ovarian, Cancer (With or Without Metastasis), Cancer (Solid Tumors), Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative, Cancer Abdomen.
Who is sponsoring clinical trial NCT07433660?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07433660 being conducted?
This trial has 5 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer - Ovarian
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia